Influence of Circulating Endothelial Progenitor Cells and Modifiable Vascular Risk Factors on Carotid Plaque Vulnerability "IMPROVE"

Recruiting

Phase N/A Results N/A

Trial Description

Ischemic stroke is a leading cause of death and disability worldwide. Atherosclerosis, responsible for the 20% of ischemic strokes, is characterized by lipid accumulation in the artery wall that leads to chronic inflammation, cell proliferation and ultimately to vessel stenosis. One of the main features related to plaque progression and vulnerability is inflammation. Positron emission tomography with 18-fluorodeoxyglucos (18-FDG PET) allows an accurate quantification of plaque inflammation and it has been proved its usefulness in predicting early stroke recurrences. The investigators aim to test how modifiable vascular risk factors influence plaque inflammation assessed by 18-FDG PET. In addition, investigators will assess the association of this inflammation and circulating endothelial progenitor cells

Conditions

Trial Population

Adult patients diagnosed of ischemic stroke presenting at least on atherosclerotic plaque in the internal carotid artery ipsilateral to stroke

Outcomes

Type Measure Time Frame Safety Issue
Primary Change in the Standardized Uptake Value (SUV) of the internal carotid artery Baseline and at one year follow-up
Primary Change in the Target-to-Background Ratio (TBR) of the internal carotid artery Baseline and at one year follow-up
Primary Change in the Endothelial Progenitor Cells Count Baseline and at one year follow-up

Sponsors